Cargando…
Antidyskinetic Treatment with MTEP Affects Multiple Molecular Pathways in the Parkinsonian Striatum
Parkinson's disease is characterized by dopaminergic neuron loss and dopamine (DA) depletion in the striatum. Standard treatment is still focused on the restoration of dopamine with exogenous L-Dopa, which however causes L-Dopa-induced dyskinesia (LID). Several studies have shown that antagonis...
Autores principales: | Lin, Jing-ya, Liu, Zhen-guo, Xie, Cheng-long, Song, Lu, Yan, Ai-juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682907/ https://www.ncbi.nlm.nih.gov/pubmed/29209553 http://dx.doi.org/10.1155/2017/5798734 |
Ejemplares similares
-
Antidyskinetic Effects of MEK Inhibitor Are Associated with Multiple Neurochemical Alterations in the Striatum of Hemiparkinsonian Rats
por: Chen, Guiqin, et al.
Publicado: (2017) -
The Antiparkinsonian and Antidyskinetic Mechanisms of Mucuna pruriens in the MPTP-Treated Nonhuman Primate
por: Lieu, Christopher A., et al.
Publicado: (2012) -
Anxiolytic Effects of Buspirone and MTEP in the Porsolt Forced Swim
Test
por: Lee, Kaziya M, et al.
Publicado: (2017) -
The NICE Medical Technologies Evaluation Programme (MTEP): manufacturer submission challenges
por: Sprange, Kirsty, et al.
Publicado: (2012) -
Repairing the Aged Parkinsonian Striatum: Lessons from the Lab and Clinic
por: Mercado, Natosha M, et al.
Publicado: (2016)